Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors

NCT00499291 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

NETWORK

Sponsor class

Conditions

Cancer

Interventions

DRUG: paclitaxel albumin-stabilized nanoparticle formulation
PROCEDURE: gene expression analysis
PROCEDURE: laboratory biomarker analysis
PROCEDURE: pharmacological study
PROCEDURE: polymerase chain reaction

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]